These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 776591)

  • 1. [A new synthetic antiparkinsonian drug, tropatepine hydrochloride in extrapyramidal syndromes induced by neuroleptics].
    Lambert A; dachary JM; Marie C; Oules J; Pagot R; Sales M; Vauterin C
    Encephale; 1976; 2(2):115-21. PubMed ID: 776591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical study of a new agent correcting the syndrome of neuroleptic impregnation in acute psychotic states].
    Vauterin C; Veillon F
    Encephale; 1975; 1(1):61-8. PubMed ID: 1093847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiparkinson medication in the treatment of extrapyramidal side effects: single of multiple daily doses?
    Neu C; Dimascio A; Demirgian E
    Curr Ther Res Clin Exp; 1972 May; 14(5):246-51. PubMed ID: 4623975
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuroleptic induced extrapyramidal symptoms.
    Donlon PT; Stenson RL
    Dis Nerv Syst; 1976 Nov; 37(11):629-35. PubMed ID: 136337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical trial of tropatepine chlorhydrate as a corrector of syndromes due to neuroleptics].
    Delaunay J; Guibert S
    Ann Med Psychol (Paris); 1976 Jan; 1(1):144-7. PubMed ID: 970819
    [No Abstract]   [Full Text] [Related]  

  • 6. [Trial of interruption of antiparkinson drugs in long term treatments with neuroleptics].
    Caroli F; Littre-Poirier MF; Ginestet D; Deniker P
    Encephale; 1975; 1(1):69-74. PubMed ID: 805695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Extra-pyramidal syndrome caused by neuroleptics].
    Lambert PA
    Encephale; 1973; 62(1):78-105. PubMed ID: 4718697
    [No Abstract]   [Full Text] [Related]  

  • 8. [Study of the delayed-action form of a synthetic antiparkinsonian drug: Akineton].
    Kammerer T; Schweitzer-Bucher E; Jamet P; Royer M
    Ann Med Psychol (Paris); 1972 May; 1(5):688-96. PubMed ID: 5081112
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experimental design of a pilot study on amantadine in the extrapyramidal syndrome induced by neuroleptic drugs].
    Ferrari P; Robotti E; Nardini M
    Boll Chim Farm; 1972 Oct; 111(10):610-5. PubMed ID: 4566407
    [No Abstract]   [Full Text] [Related]  

  • 10. Dexetimide (R 16470) in the control of neuroleptic-induced extrapyramidal side-effects. Its prophylactic value and duration of action.
    Huygens H; Vereecken JL; Tanghe A
    Psychiatr Neurol Neurochir; 1973; 76(4):251-9. PubMed ID: 4581374
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antagonism between anti-Parkinson drugs and neuroleptics. Apropos of various withdrawal experiences, a personal one among them (2nd part)].
    Bourgeois M; Bouey P
    Ann Med Psychol (Paris); 1976 Nov; 2(4):669-708. PubMed ID: 1020864
    [No Abstract]   [Full Text] [Related]  

  • 12. Ethylbenzatropine for acute neurological and mental side effects after tranquillisers.
    Molcan J; Floreánová L; Polák L
    Act Nerv Super (Praha); 1972; 14(2):97. PubMed ID: 5040183
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical evaluation of amantadine in the treatment of extrapyramidal syndromes caused by neuroleptic drugs].
    Bukowczyk A; Wasik A; Horodnicki J
    Psychiatr Pol; 1974; 8(2):143-8. PubMed ID: 4830321
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of the neuroleptic syndrome by biperiden hydrochloride under its delayed-action form. A 9-month study on 55 hospitalized patients].
    Verdeau-Pailles J
    Encephale; 1976; 2(4):341-7. PubMed ID: 1001242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amantadine in drug-induced extrapyramidal signs: a comparative study.
    Ananth J; Sangani H; Noonan JP
    Int J Clin Pharmacol Biopharm; 1975 Jun; 11(4):323-6. PubMed ID: 239908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical observations of the treatment of tardive dyskinesia with haloperidol.
    Frangos E; Christodoulides H
    Acta Psychiatr Belg; 1975 Jan; 75(1):19-32. PubMed ID: 785948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of Parkinson's disease and extrapyramidal syndromes with classical drugs (what can be expected from them in the levodopa era and which should be used)].
    Sigwald J
    Therapeutique; 1972 Nov; 48(9):561-8. PubMed ID: 4650525
    [No Abstract]   [Full Text] [Related]  

  • 18. Extrapyramidal side effects and oral haloperidol: an analysis of explanatory patient and treatment characteristics.
    Moleman P; Schmitz PJ; Ladee GA
    J Clin Psychiatry; 1982 Dec; 43(12):492-6. PubMed ID: 7161250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treating extrapyramidal reactions: some current issues.
    Gelenberg AJ
    J Clin Psychiatry; 1987 Sep; 48 Suppl():24-7. PubMed ID: 2887554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tranquilizing agents: extrapyramidal and antiparkinsonism activities].
    Bordeleau JM; Tétreault L; Elie R
    Vie Med Can Fr; 1972 Feb; 1(2):118-26. PubMed ID: 4637390
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.